Related Experiment Video
Updated: Mar 27, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
2.0K
A large language model-based self-learning and critical agent framework for multimodal Alzheimer's disease diagnosis
Meiwei Zhang1, Qiushi Cui1, Yang Lü2
1College of Electrical Engineering, Chongqing University.
Neuropsychology
|March 26, 2026
Summary
A novel large language model (LLM) multiagent framework simulates Alzheimer's disease diagnosis using multimodal data. This training-free approach achieves 88% F1 score, offering transparent reasoning for complex neuropsychological cases.
Area of Science:
- Artificial Intelligence
- Computational Neuroscience
- Medical Diagnostics
Background:
- Alzheimer's disease diagnosis relies on integrating complex, multimodal data.
- Current diagnostic methods can be time-consuming and lack transparency in reasoning.
- Large Language Models (LLMs) offer potential for advanced data analysis and decision support.
Purpose of the Study:
- To develop and evaluate a training-free LLM multiagent framework for simulating team-based Alzheimer's disease diagnosis.
- To enhance the interpretability and generalizability of diagnostic processes using multimodal data.
- To leverage LLMs for transparent and accurate neuropsychological diagnosis.
Main Methods:
- A self-learning and critical multiagent workflow was designed, comprising single-dimension and senior agents with intelligence and experience-retrieval modules.
- The framework was evaluated on 1,362 Alzheimer's Disease Neuroimaging Initiative (ADNI) records across different cognitive statuses.
- No end-to-end fine-tuning or supervision on ADNI labels was performed, ensuring a training-free approach.
Main Results:
- The integrated multiagent framework achieved an 88% F1 score, 88% sensitivity, and 90% precision for classifying cognitively normal, mild cognitive impairment, and Alzheimer's disease.
- The system provided case-level rationales, demonstrating transparent reasoning capabilities.
- Sequential self-learning and critique significantly improved performance compared to early agent iterations.
Conclusions:
- A label-free LLM multiagent approach effectively integrates heterogeneous data modalities for Alzheimer's disease diagnosis.
- The framework demonstrates competitive accuracy and retains diagnostic experience, offering transparent reasoning.
- This approach shows promise for real-world clinical support in complex neuropsychological diagnosis.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K

